Affiliations: 1 Institute for Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.
2 BioHealth Graz, Graz, Austria.
3 BioTechMed Graz, Graz, Austria.
Keywords:
Candida, resistance, antifungals, yeast, antimycotics, drug, azoles
Related Article(s)?
Corresponding Author(s):
Didac Carmona-Gutierrez, Institute of Molecular Biosciences, University of Graz, Graz, Austria; carmonag@uni-graz.at
Frank Madeo, Institute of Molecular Biosciences, University of Graz, Graz, Austria; madeo@uni-graz.at
Conflict of interest statement:
D.C-G. and F.M. are the scientific co-founders of Samsara Therapeutics, a company that develops novel pharmaco-logical autophagy inducers. F.M. and D.C-G. have equity interests in TLL (The Longevity Labs), a company that develops natural food extracts.
Please cite this article as:
Katharina Kainz, Maria A. Bauer, Didac Carmona-Gutierrez and Frank Madeo (2020). Fungal infections: the hidden crisis. <bMicrobial Cell 7(6): 143-145. doi: 10.15698/mic2020.06.718
© 2020 Kainz et al. This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduc-tion in any medium, provided the original author and source are acknowledged.
Fungal infections in humans: the silent crisis
Authors:Katharina Kainz1, Maria A. Bauer1, Frank Madeo1-3 and Didac Carmona-Gutierrez1
1 Institute for Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.
2 BioHealth Graz, Graz, Austria.
3 BioTechMed Graz, Graz, Austria.
Keywords:
Candida, resistance, antifungals, yeast, antimycotics, drug, azoles
Related Article(s)?
Corresponding Author(s):
Conflict of interest statement:
D.C-G. and F.M. are the scientific co-founders of Samsara Therapeutics, a company that develops novel pharmaco-logical autophagy inducers. F.M. and D.C-G. have equity interests in TLL (The Longevity Labs), a company that develops natural food extracts.
Please cite this article as:
Katharina Kainz, Maria A. Bauer, Didac Carmona-Gutierrez and Frank Madeo (2020). Fungal infections: the hidden crisis. <bMicrobial Cell 7(6): 143-145. doi: 10.15698/mic2020.06.718
© 2020 Kainz et al. This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduc-tion in any medium, provided the original author and source are acknowledged.
Abstract:
Annually, over 150 million severe cases of fungal infections occur worldwide, resulting in approximately 1.7 million deaths per year. Alarmingly, these numbers are continuously on the rise with a number of social and medical developments during the past decades that have abetted the spread of fungal infections. Additionally, the long-term therapeutic application and prophylactic use of antifungal drugs in high-risk patients have promoted the emergence of (multi)drug-resistant fungi, including the extremely virulent strain Candida auris. Hence, fungal infections are already a global threat that is becoming increasingly severe. In this article, we underline the importance of more and effective research to counteract fungal infections and their consequences.
doi: 10.15698/mic2020.06.718
Volume 7, pp. 143 to 145, published 01/06/2020.